| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Oaktree Acquisition Corp. III Life Sciences
13G
OACC · G6717R104
|
22.3% |
2/12/2025
Event 12/31/2024
|
||||
| Oaktree Acquisition Holdings III LS, LLC | 22.3% | |||||
| Oaktree Acquisition Holdings III LS GP, Ltd. | 22.3% | |||||
| Oaktree Capital Holdings, LLC | 22.3% | |||||
| Oaktree Capital Group Holdings GP, LLC | 22.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.